These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25091190)

  • 1. Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.
    Hauff SJ; Raju SC; Orosco RK; Gross AM; Diaz-Perez JA; Savariar E; Nashi N; Hasselman J; Whitney M; Myers JN; Lippman SM; Tsien RY; Ideker T; Nguyen QT
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):612-8. PubMed ID: 25091190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of squamous cell carcinoma in carcinogen induced oral cancer rodent model by ratiometric activatable cell penetrating peptides.
    Hingorani DV; Lemieux AJ; Acevedo JR; Glasgow HL; Kedarisetty S; Whitney MA; Molinolo AA; Tsien RY; Nguyen QT
    Oral Oncol; 2017 Aug; 71():156-162. PubMed ID: 28688684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma.
    Raju SC; Hauff SJ; Lemieux AJ; Orosco RK; Gross AM; Nguyen LT; Savariar E; Moss W; Whitney M; Cohen EE; Lippman SM; Tsien RY; Ideker T; Advani SJ; Nguyen QT
    Oral Oncol; 2015 May; 51(5):470-5. PubMed ID: 25735654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma.
    Yoshizaki T; Sato H; Maruyama Y; Murono S; Furukawa M; Park CS; Seiki M
    Cancer; 1997 Jan; 79(1):139-44. PubMed ID: 8988738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo optical imaging of folate receptor-β in head and neck squamous cell carcinoma.
    Sun JY; Shen J; Thibodeaux J; Huang G; Wang Y; Gao J; Low PS; Dimitrov DS; Sumer BD
    Laryngoscope; 2014 Aug; 124(8):E312-9. PubMed ID: 24448885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical molecular navigation with ratiometric activatable cell penetrating peptide for intraoperative identification and resection of small salivary gland cancers.
    Hussain T; Savariar EN; Diaz-Perez JA; Messer K; Pu M; Tsien RY; Nguyen QT
    Head Neck; 2016 May; 38(5):715-23. PubMed ID: 25521629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib-associated matrix metalloproteinase suppression in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
    Umbreit C; Aderhold C; Faber A; Sauter A; Hofheinz RD; Stern-Straeter J; Hoermann K; Schultz JD
    Oncol Rep; 2014 Aug; 32(2):668-76. PubMed ID: 24890748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P; Khantapura P
    Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targeting of papillary thyroid carcinoma with fluorescently labeled ratiometric activatable cell penetrating peptides in a transgenic murine model.
    Orosco RK; Savariar EN; Weissbrod PA; Diaz-Perez JA; Bouvet M; Tsien RY; Nguyen QT
    J Surg Oncol; 2016 Feb; 113(2):138-43. PubMed ID: 26799257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.
    Arosarena OA; Barr EW; Thorpe R; Yankey H; Tarr JT; Safadi FF
    J Cell Physiol; 2018 Jan; 233(1):409-421. PubMed ID: 28295306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma.
    Imanishi Y; Fujii M; Tokumaru Y; Tomita T; Kanke M; Kanzaki J; Kameyama K; Otani Y; Sato H
    Hum Pathol; 2000 Aug; 31(8):895-904. PubMed ID: 10987249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoinositide kinase-3 status associated with presence or absence of human papillomavirus in head and neck squamous cell carcinomas.
    Yarbrough WG; Whigham A; Brown B; Roach M; Slebos R
    Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S98-101. PubMed ID: 17848307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of programmed-death ligand in the human head and neck squamous cell carcinoma microenvironment is mediated through matrix metalloproteinase-mediated proteolytic cleavage.
    Hira-Miyazawa M; Nakamura H; Hirai M; Kobayashi Y; Kitahara H; Bou-Gharios G; Kawashiri S
    Int J Oncol; 2018 Feb; 52(2):379-388. PubMed ID: 29345283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
    Birkedal-Hansen B; Pavelic ZP; Gluckman JL; Stambrook P; Li YQ; Stetler-Stevenson WG
    Oral Dis; 2000 Nov; 6(6):376-82. PubMed ID: 11355270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
    Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
    BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts.
    Rosenthal EL; Kulbersh BD; King T; Chaudhuri TR; Zinn KR
    Mol Cancer Ther; 2007 Apr; 6(4):1230-8. PubMed ID: 17431103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-2 and -14 in p16-positive and -negative HNSCC after exposure To 5-FU and docetaxel In Vitro.
    Aderhold C; Umbreit C; Faber A; Birk R; Sommer JU; Hörmann K; Schultz JD
    Anticancer Res; 2014 Sep; 34(9):4929-37. PubMed ID: 25202075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
    Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
    Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.
    Dixit R; Kemp C; Kulich S; Seethala R; Chiosea S; Ling S; Ha PK; Duvvuri U
    Sci Rep; 2015 Nov; 5():16657. PubMed ID: 26563938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma.
    Wiegand S; Dünne AA; Müller HH; Mandic R; Barth P; Davis RK; Werner JA
    Cancer; 2005 Jul; 104(1):94-100. PubMed ID: 15912516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.